Knowing is not enough; we must apply: the case for rigorous microRNA annotation standards
Nucleic Acids Research · 14.10.2025 · 53 (19)
DOI: 10.1093/nar/gkaf1049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 21.10.2025. Verfasst von Michael Hackenberg und 4 weiteren Autor:innen. Beteiligte Einrichtung: Bioinformatics Laboratory, Biotechnology Institute & Biomedical Research Centre (CIBM), Avenida del Conocimiento 19, Granada 18100, Spain. Hauptthemen laut MEDLINE: MicroRNAs, Molecular Sequence Annotation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: TromsøForskningsstiftelse.
Abstract (Originalsprache)
MicroRNAs are by far the most extensively studied and best-characterized class of small RNAs. This depth of knowledge may partly explain the persistent eagerness in the field to classify new sequences as microRNAs—since labeling a molecule as such often implies immediate functional insight and biological relevance. However, this enthusiasm has led to the publication and deposition of thousands of spurious microRNA entries in public repositories, increasing the risk of misinterpretation—particularly when these sequences are linked to human disease. To address this, we present a concise, four-part checklist for evaluating putative microRNAs, based on structural, genomic, functional, and expression-related criteria. Applying it to “Mir-690” and nine other examples, which are not listed in the curated microRNA database MirGeneDB, but highly cited, we find no support for their classification as microRNAs. They fail to meet core microRNA annotation criteria, lack structural features, conservation of targets, and reproducible or microRNA-typical expression evidence. Our findings underscore the need for heightened scrutiny and standardized validation in microRNA research. The checklist we provide offers a practical tool for authors, editors, reviewers, and readers to critically assess microRNA claims—particularly when such sequences are proposed as biomarkers or therapeutic targets in translational studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Bioinformatics Laboratory, Biotechnology Institute & Biomedical Research Centre (CIBM), Avenida del Conocimiento 19, Granada 18100, Spain.
- Department of Genetics, Faculty of Sciences, University of Granada, Avenida de la Fuente Nueva S/N, C.P. Granada 18071, Spain.
- Science for Life Laboratory, Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, 11418 Stockholm, Sweden.
- Department of Biological Sciences, Dartmouth College Hanover, Hanover, NH 03755 United States.
- The Arctic University Museum of Norway, UiT - The Arctic University of Norway, 9006 Tromsø, Norway.
ORCID-Profile: Michael Hackenberg, Panagiotis Kalogeropoulos, Kevin J Peterson, Marc R Friedländer, Bastian Fromm
Förderung
- TromsøForskningsstiftelse
Zitieren
APA
Hackenberg, M., Kalogeropoulos, P., Peterson, K. J., Friedländer, M. R., & Fromm, B. (2025). Knowing is not enough; we must apply: the case for rigorous microRNA annotation standards. Nucleic Acids Research, 53(19). https://doi.org/10.1093/nar/gkaf1049
Vancouver
Hackenberg M, Kalogeropoulos P, Peterson KJ, Friedländer MR, Fromm B. Knowing is not enough; we must apply: the case for rigorous microRNA annotation standards. Nucleic Acids Research. 2025;53(19). doi:10.1093/nar/gkaf1049
BibTeX
@article{Hackenberg2025,
author = {Hackenberg, Michael and Kalogeropoulos, Panagiotis and Peterson, Kevin J and Friedländer, Marc R and Fromm, Bastian},
title = {Knowing is not enough; we must apply: the case for rigorous microRNA annotation standards},
journal = {Nucleic Acids Research},
year = {2025},
volume = {53},
number = {19},
doi = {10.1093/nar/gkaf1049}
}
EUVIMED